Indirect targeting of MYC sensitizes pancreatic cancer cells to mechanistic target of rapamycin (mTOR) inhibition.
Christian SchneeweisZonera HassanKatja AscherlMatthias WirthStella KoutsouliFelix OrbenLukas KraußCarolin SchneiderRupert ÖllingerOliver H KrämerRoland RadMaximilian ReichertMaria S RoblesDieter SaurGünter SchneiderPublished in: Cancer communications (London, England) (2022)